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Attempts to identify susceptibility loci that, on their own, have marginal main effects by use of gene-gene interaction
tests have increased in popularity. The results obtained from analyses of epistasis are, however, difficult to interpret.
Gene-gene interaction, albeit only marginally significant, has recently been reported for the interleukin-4 and
interleukin-13 genes (IL4 and IL13) with the interleukin-4 receptor A gene (IL4RA), contributing to the susceptibility
of type 1 diabetes (T1D). We aimed to replicate these findings by genotyping both large family and case-control
data sets and by using previously published data. Gene-gene interaction tests were performed using linear regression
models in cases only. We did not find any single-locus associations with T1D and did not obtain evidence of gene-
gene interaction. Additional support from independent samples will be even more important in the study of gene-
gene interactions and other subgroup analyses.
The genetic analysis of common, multifactorial diseases,
such as type 1 diabetes (T1D [MIM 222100]), that are
highly clustered in families is proving to be a challenging
task (Altmuller et al. 2001; Hirschhorn et al. 2002; Ioan-
nidis et al. 2003; Wang et al. 2005). There are many
reasons for this, including statistically underpowered
small sample sizes; lack of coverage of the genome due
to technical, and thus cost, limitations in genotyping;
and statistical issues, such as subgroup analyses and very
low prior probability of obtaining a true result (Dahl-
man et al. 2002; Thomas and Clayton 2004; Wang et
al. 2005). One possibility, which is gaining popularity
among some authors (Culverhouse et al. 2002; Moore
2003; Hoh and Ott 2004), is that susceptibility gene
effects may be only identified in analyses of statistical
interaction, since the individual marginal effects may be
close to null. However, these extreme models of epistasis
are difficult to explain biologically. Furthermore, the in-
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terpretation of statistical interaction in terms of “epi-
static” mechanisms is problematic (Cordell 2002).
Whether testing for interactions or subgroup analyses
increases the power to detect disease susceptibility genes
or not, such approaches may exacerbate the problem of
false positives due to the even lower prior probability
of detecting a true positive (Thomas and Clayton 2004;
Wang et al. 2005). Subsequently, for reliable gene-gene
interaction results, very small P-value thresholds, less
than , and larger sample sizes, in addition to6P ! 10
replication in independent samples, may be required.
Recently, in a sample of 90 cases of T1D and 94
Filipino population-based controls, Bugawan et al.
(2003) reported evidence of an interaction between 10
SNPs in the interleukin-4 receptor A gene (IL4RA
[MIM 147781]) on chromosome 16p11-p12 (SNPs 5′
3223CrT [rs2057768], 5′ 1914CrT [rs2107356],
I50V [rs1805010], N142N [rs2234895], E375A
[rs1805011], L389L [rs2234898], C406R [rs1805012],
S478P [rs1805015], Q551R [rs1801275], and S761P
[rs1805014]) and 5 SNPs in the adjacent interleukin-4
and interleukin-13 genes (IL4 [MIM 147780] and
IL13 [MIM 147683]) on chromosome 5q31 (SNPs 5′
524TrC [rs2243250] in IL4 and 5′ 1512ArC
[rs1881457], 5′ 1112CrT [rs1800925], 1923CrT/
intron 3 [rs1295686], and R110Q [rs20541] in IL13).
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Table 1
Association Analysis of IL4, IL13, and IL4RA SNPs in a T1D Case-Control Sample
GENE AND SNP dbSNP
NUCLEOTIDE
CHANGE
NO. OF CONTROLS
WITH GENOTYPE
NO. OF CASES
WITH
GENOTYPE
MAF FOR
PControls Cases
IL4:
5′ 524 rs2243250 TrC 1,622 1,557 .13 .14 .47
IL13:
5′ 1512 rs1881457 ArC 1,655 1,578 .19 .17 .87
5′ 1112 rs1800925 CrT 1,660 1,583 .18 .17 .83
1923 rs1295686 CrT 1,624 1,559 .18 .18 .43
R110Q rs20541 GrA 1,653 1,559 .17 .18 .41
IL4RA:
5′ 3223 rs2057768 CrT 1,578 1,592 .30 .29 .46
I50V rs1805010 ArG 1,582 1,583 .46 .45 .48
E375A rs1805011 ArC 1,622 1,565 .12 .12 .79
C406R rs1805012 TrC 1,674 1,575 .11 .11 .49
S411L rs1805013 CrT 1,653 1,587 .05 .05 .16
S478P rs1805015 TrC 1,639 1,584 .18 .17 .35
Q551R rs1801275 ArG 1,673 1,590 .22 .22 .73
S761P rs1805014 TrC 1,644 1,590 .01 .01 .87
NOTE.—To correct for regional variation in allele frequencies, the analyses were stratified according to 12 broad
geographical regions within Great Britain (D.G.C., unpublished data). Note that, for every SNP, genotyping of DNA
samples from 1,829 controls and 1,616 patients with T1D was attempted. The numbers of cases and controls,
MAFs of cases and controls, and P values were obtained by association analyses with T1D.
Of these 15 SNPs, 4 showed some evidence of primary
disease association—namely, E375A ( ), L389LP p .02
( ), and C406R ( ) in IL4RA and the 5′P p .001 P p .05
1512ArC SNP in IL13 ( ). Furthermore, atP p .05
IL4RA, a 7-locus haplotype ( ) and a 10-locusP p .005
haplotype ( ) showed some evidence of asso-P p .001
ciation. Additional effects of five-locus haplotypes at IL4
and IL13 (smallest P value p .004) were observed, as
well as gene-gene interaction of the IL4 and IL13 loci
with IL4RA ( ) (Bugawan et al. 2003). NoteP ! .045
that, to correct for multiple testing, Bugawan et al.
(2003) permutated genotypes at chromosomes 5 and 16
within patients and controls, keeping genotype frequen-
cies constant. The P values were !.05, but, nevertheless,
if the reported effect were true, then a much larger study
should confirm the result. Given the linkage and asso-
ciation results from studies of T1D and other diseases
that are inherited in a similarly complex way, it is likely
that non–human leukocyte antigen T1D-susceptibility
loci will have effect sizes with odds ratios (ORs) !2.0
(Wang et al. 2005). However, since the sample size used
by Bugawan et al. (2003) is very small (90 cases and 94
controls) for purposes of detecting a true effect, the effect
size would need to be in considerable excess of OR 2.0
for the minor allele. Since the effects reported here for
minor alleles are much smaller than this, the posterior
probability that Bugawan et al. (2003) have detected a
true effect is very small. In this study, we attempted
replication of the main findings reported by Bugawan et
al., using a larger sample of up to 748 multiplex families
and up to 1,616 cases and 1,829 controls.
First, we tested the primary, single-locus association
of the 15 SNPs from IL4, IL13, and IL4RA in a white
British case-control sample. The case-control DNA set
consisted of 1,616 white individuals with T1D who
were recruited from across Britain for the Juvenile
Diabetes Research Foundation/Wellcome Trust–funded
U.K. GRID study (see U.K. GRID Study Web site), and
1,829 population-based controls from the 1958 British
Birth Cohort (see National Child Development Study
Web site). The mean age at onset of the patients, who
were all !16 years old at diagnosis, is 7.5 years (SD 4
years). We obtained no evidence of association with T1D
(table 1). The SNPs included IL13 R110Q, which
showed some evidence of association in previous stud-
ies (Bugawan et al. 2003). Genotyping of IL4RA
L389L was not performed, since this variant is in very
strong linkage disequilibrium with its neighboring SNPs
E375A, C406R, and Q551R (Bugawan et al. 2003). We
employed the Invader (Third Wave Technologies) and
TaqMan (Applied Biosystems) genotyping technologies.
Primer and probe sequences are shown in tables A1 and
A2 (online only). The IL4RA results were consistent
with our previous study of 3,475 families with T1D
(Maier et al. 2003), in that no P values !.05 were ob-
tained. There was also no evidence for the previously
suggested IL13 R110Q and E375A genotype associa-
tions: the OR was 0.90 (95% CI 0.77–1.06) for the IL13
R110Q AG heterozygote and 1.05 (95% CI 0.88–1.26)
for the E375A AC heterozygote. Furthermore, no evi-
dence was obtained for the previously reported associ-
ations of the IL4RA 3223CrT SNP ( ) (MaierP 1 .05
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Table 2
P Values Obtained by Regression Analyses of Interactions of IL13 and IL4 SNPs with Eight IL4RA SNPs for Susceptibility to T1D
GENE AND SNP (dbSNP)
IL4RA SNP (dbSNP)
5′ 3223
(rs2057768)
I50V
(rs1805010)
E375A
(rs1805011)
C406R
(rs1805012)
S411L
(rs1805013)
S478P
(rs1805015)
Q551R
(rs1801275)
S761P
(rs1805014)
IL4:
5′ 524 (rs2243250) .92 .56 .98 .96 .45 .93 .61 .55
IL13:
5′ 1512 (rs1881457) .63 .87 .95 .54 .80 .70 .34 .43
5′ 1112 (rs1800925) .48 .68 .99 .52 .98 .81 .52 .43
1923 (rs1295686) .41 .37 .98 .47 .75 .39 .61 .79
R110Q (rs20541) .38 .43 .26 .53 .64 .35 .62 .45
NOTE.—Results are shown for a sample of 1,616 white patients. To correct for regional variation in allele frequencies, the analyses were
stratified according to 12 broad geographical regions within Great Britain (D.G.C., unpublished data).
et al. 2003) or for that of a six-locus IL4RA haplo-
type ( ) (Mirel et al. 2002; Bugawan et al. 2003;P 1 .05
Maier et al. 2003). We have analyzed two haplotypes,
one consisting of IL4RA I50V (rs1805010), E375A
(rs1805011), C406R (rs1805012), S411L (rs1805013),
S478P (rs1805015), and Q551R (rs1801275) and the
other consisting of IL13 1512ArC (rs1881457),
IL13 1112CrT (rs1800925), IL13 1923CrT
(rs1295686), IL13 R110Q (rs20541), and IL4 524CrT
(rs2243250). However, no results with wereP ! .05
obtained, and all 95% CIs overlapped 1. Results from
haplotype analyses for IL4RA and IL4/IL13 are given
in tables A3 and A4 (online only).
We note that the minor-allele frequencies (MAFs) of
all SNPs except for IL4RA I50V and S478P are lower
in our U.K. and U.S. populations than in the 184 Filipino
subjects studied elsewhere (Bugawan et al. 2003). How-
ever, the IL4RA S761P SNP, which was monomorphic
in Filipinos, was polymorphic in our population (MAF
0.01). Nevertheless, our larger data set and, hence, in-
creased statistical power should compensate for the loss
of power due to the lower MAFs.
Second, we tested for evidence of an interaction (i.e.,
deviation from a multiplicative model of epistasis) be-
tween eight IL4RA SNPs and the one IL4 and four IL13
SNPs in a case-only analysis (table 2) (Piegorsch et al.
1994; Umbach and Weinberg 1997). We assume markers
are in linkage equilibrium in the general population (i.e.,
the controls). A convenient and powerful approach is to
test the correlation coefficient between the genotypes at
the two loci, scored 0, 1, and 2 (Piegorsch et al. 1994;
Umbach and Weinberg 1997). We genotyped a DNA
collection consisting of 1,616 cases and 1,829 controls
from Great Britain, for the previously associated can-
didate SNPs. The candidate SNPs for IL4 and IL13
were IL4 524CrT (rs2243250), IL13 1512ArC
(rs1881457), IL13 1112CrT (rs1800925), IL13
1923CrT (rs1295686), and IL13 R110Q (rs20541).
We did not observe any evidence of interaction between
single SNPs in our data set ( ) (table 2).P 1 .05
Third, we considered the possibility that there is a true
association and that the etiological variant has not been
identified yet. To ensure that we captured the informa-
tion in the IL4 and IL13 regions, we genotyped tagSNPs
for both genes, using 748 white families with T1D from
the United Kingdom and the United States, to perform
further interaction analyses with IL4RA. The families
with T1D each included two parents and at least one
affected child. The 748 families with T1D comprised
472 multiplex families from the U.K. Warren 1 reposi-
tory (Bain et al. 1990) and 276 multiplex families from
the Human Biological Data Interchange ascertained in
the United States (Lernmark 1991), with inclusion cri-
teria described elsewhere (Vella et al. 2004). The se-
quencing data and genotypes of a sequencing panel re-
quired for the tagging approach were obtained from
the University of Washington–Fred Hutchinson Cancer
Research Center (UW-FHCRC) Cancer Variation Dis-
covery Resource (SeattleSNPs), published at the UW-
FHCRC Web site. From this resource, we downloaded
data on common polymorphisms of exons and introns
from 23 white individuals (from Centre d’Etude du Poly-
morphism Humain [CEPH]) and used these to select
tagSNPs. For IL4 and IL13, 12 and 6 tagSNPs, respec-
tively, with MAFs 10.05, were selected as described else-
where (Chapman et al. 2003; Clayton et al. 2004) and
are listed in tables A5 and A6 (online only). With the
chosen subset of tagSNPs, the remaining SNPs were re-
quired to be predicted with a minimum locus of 0.80.2R
In total, 18 tagSNPs were selected and genotyped in
the same 748 families with T1D investigated for
IL4RA association by Maier et al. (2003). Note that,
in the selection of tagSNPs for IL4, the IL4 524
variant was selected as a tagSNP. Similarly, for IL13,
the IL13 1512ArC (rs1881457), IL13 1112CrT
(rs1800925), and IL13 1923CrT (rs1295686) vari-
ants were selected as tagSNPs.
The multilocus test (Chapman et al. 2003; Clayton et
al. 2004) P values for IL4 and IL13 were .58 and .74,
respectively, indicating that neither locus was associated
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Table 3
P Values for Interaction Tests Obtained from
Regression Analyses of IL13 and IL4 tagSNPs with
Eight IL4RA SNPs
IL4RA SNP (dbSNP)
P VALUE FOR
IL13 tagSNPs IL4 tagSNPs
5′ 3223 (rs2057768) .72 .97
I50V (rs1805010) .14 .37
E375A (rs1805011) .21 .62
C406R (rs1805012) .55 .20
S411L (rs1805013) .39 .43
S478P (rs1805015) .71 .97
Q551R (rs1801275) .65 .51
S761P (rs1805014) .55 .24
NOTE.—Results are shown for a U.K. and U.S. family
collection of up to 748 families with T1D.
with T1D in this U.K. and U.S. family collection, which
is consistent with the data obtained in our U.K. case-
control collection. We tested for interaction, a deviation
from the model of multiplicative effect, between single
SNPs in one region or gene and a set of tagSNPs in a
second region, by regressing the genotype at the single
SNP on all tag genotypes in cases. For each IL4RA locus,
we used this regression technique to test for an inter-
action between specific IL4RA loci and the IL4 region,
as well as the IL13 region. As shown in table 3, neither
IL4 nor IL13 tagSNPs showed P values !.05 with eight
IL4RA SNPs for an interaction effect. For completeness,
we also performed the same test employed by Bugawan
et al. (2003) in both a case-control and case-only design
for interaction between IL4RA SNPs and IL13 tagSNPs
and between IL4RA SNPs and IL4 tagSNPs, but ob-
tained no evidence of interaction ( ).P 1 .05
We conclude that there is no evidence of interaction
between the IL4RA and the IL13 or IL4 loci in suscep-
tibility to T1D, with regard to the investigated variants
in our populations of European descent. The previously
published result obtained in 184 individuals from the
Philippines may be specific to that sample population,
but a study of such small size has minimal power to
detect a true interaction effect. In comparing the study
of Bugawan et al. (2003) with our study, it is evident
that the present study has substantially greater statistical
power. This is because we not only used a larger sample
size but also employed regression analyses that use only
cases, and this approach has been shown elsewhere to
be more powerful when the assumption of independence
is true (Piegorsch et al. 1994; Umbach and Weinberg
1997). Failure to replicate genetic association studies is
well documented in the literature and, even though sev-
eral reasons have been reported—including allelic het-
erogeneity, true variation in disease association between
populations, modifying genetic and/or environmental
factors, and misclassification of outcome—the most im-
portant factor is probably insufficient and/or inadequate
sample sizes in the context of a very-low prior proba-
bility of detecting a true effect (Clayton and McKeigue
2001; Dahlman et al. 2002; Hirschhorn et al. 2002;
Colhoun et al. 2003; Ioannidis et al. 2003; Lohmueller
et al. 2003; Thomas and Clayton 2004; Wang et al.
2005). Such problems will be much more extreme for
reported gene-gene interactions; power to detect inter-
action is low and the problems of low prior probability
and subgroup analyses are more extreme. These results
highlight the necessity of attempting replication in in-
dependent samples before drawing conclusions about
a potential disease-susceptibility locus or gene-gene
interaction.
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